International Conference on Medical and Health Sciences

  20 Mar 2024 - 21 Mar 2024

   Cambridge, United Kingdom

conference-img

International Conference on Medical and Health Sciences

20 Mar 2024

 - 

21 Mar 2024

Cambridge, United Kingdom



ICMHS 2024 in Cambridge, UK, by SciencePlus Global Research Forum, is a premier international conference for Medical and Health Sciences. Join leading researchers to exchange insights, discuss innovations, and present new research findings. Submit your work and connect with experts worldwide.

ICMHS 2024 offers a platform for exploring cutting-edge research and global collaboration in Medical and Health Sciences, fostering knowledge exchange and insights into emerging trends.

International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026


International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in "next generation" photoactive cancer therapy

2.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

3.

The American College of Physicians updated its recommendations for colorectal cancer screening.

4.

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

5.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot